ArticlePloS one2026

Real-world clinical effectiveness of trimethoprim-sulfamethoxazole for primary prophylaxis of pneumocystis pneumonia in non-hodgkin lymphoma patients treated with rituximab.

Patcharaporn Charoenrit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.